As on 13-Aug-2024 IST
₹573.15
₹580.55
₹597.55
₹568.00
51,461
₹395.00 - 631.00
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|
---|---|---|---|---|---|---|---|
Unichem Lab
| 40.97 | 7.54 | 0.80 | 40.57 | 24.12 | 26.28 | 10.21 |
BSE Healthcare
| 30.05 | 6.86 | 18.26 | 46.79 | 16.31 | 26.45 | 12.81 |
BSE Small Cap
| 24.81 | -1.39 | 17.32 | 50.92 | 26.42 | 33.21 | 18.27 |
2023
|
2022
|
2021
|
2020
|
2019
|
2018
|
2017
|
|
---|---|---|---|---|---|---|---|
Unichem Lab
| 28.61 | 26.87 | -4.53 | 61.98 | -16.52 | -41.42 | 29.14 |
BSE Small Cap
| 47.52 | -1.80 | 62.77 | 32.11 | -6.85 | -23.41 | 59.64 |
BSE Healthcare
| 36.97 | -12.10 | 20.87 | 61.45 | -3.55 | -5.89 | 0.49 |
Stock
|
Peer Median
|
||
---|---|---|---|
Please wait... |
Stock
|
Peer Median
|
||
---|---|---|---|
Please wait... |
The total asset value of Unichem Laboratories Ltd stood at ₹ 3,169 Cr as on 30-Jun-24
The share price of Unichem Laboratories Ltd is ₹572.20 (NSE) and ₹572.65 (BSE) as of 13-Aug-2024 IST. Unichem Laboratories Ltd has given a return of 24.12% in the last 3 years.
Unichem Laboratories Ltd has a market capitalisation of ₹ 4,032 Cr as on 13-Aug-2024. As per Value Research classification, it is a Small Cap company.
The P/B ratio of Unichem Laboratories Ltd is 1.70 times as on 13-Aug-2024, a 51% discount to its peers’ median range of 3.50 times.
Since, TTM earnings of Unichem Laboratories Ltd is negative, P/E ratio is not available.
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the Unichem Laboratories Ltd and enter the required number of quantities and click on buy to purchase the shares of Unichem Laboratories Ltd.
Unichem Laboratories Limited, a pharmaceutical company, manufactures and sells pharmaceutical products worldwide. The company offers formulation products that address various therapeutic areas, such as gastroenterology, cardiology, diabetology, psychiatry, neurology, anti-bacterial, anti-infective, and pain management. It also offers active pharmaceutical ingredients, as well as contract manufacturing services. In addition, the company manufactures allopathic medicines, bulk drugs, and chemicals. Unichem Laboratories Limited was founded in 1944 and is based in Mumbai, India.
The prominent promoters of Unichem Laboratories Ltd. are
Name of promoters | Holding percentage |
---|---|
Ipca Laboratories Limited |
52.67%
|
Dr. Prakash Amrut Mody |
12.78%
|
Anita Prakash Mody |
1.88%
|
Suparna Prakash Mody |
1.35%
|
The chairman of the company is Prakash A Mody, and the managing director is Pabitrakumar Kalipada Bhattacharyya.
There is no promoter pledging in Unichem Laboratories Ltd.
Some of the close peers are:
Company | Market Cap(₹ Cr) |
---|---|
11,208
|
|
8,248
|
|
7,943
|
|
4,730
|
Unichem Laboratories Ltd. | Ratios |
---|---|
Return on equity(%)
|
0.02
|
Operating margin(%)
|
0.17
|
Net Margin(%)
|
-3.45
|
Dividend yield(%)
|
0
|
No, TTM profit after tax of Unichem Laboratories Ltd was ₹-61 Cr.
Unichem Laboratories Limited, a pharmaceutical company, manufactures and sells pharmaceutical products worldwide. The company offers formulation products that address various therapeutic areas, such as gastroenterology, cardiology, diabetology,... psychiatry, neurology, anti-bacterial, anti-infective, and pain management. It also offers active pharmaceutical ingredients, as well as contract manufacturing services. In addition, the company manufactures allopathic medicines, bulk drugs, and chemicals. Unichem Laboratories Limited was founded in 1944 and is based in Mumbai, India. Read more